Ginkgo Bioworks (DNA) Misses Q4 EPS by 1c

Ginkgo Bioworks (NYSE: DNA) reported Q4 EPS of ($0.11), $0.01 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $34.76 million versus the consensus estimate of $42.5 million.

For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Investing.com’s stocks of the week
• United Community Banks sells equipment finance unit for $1.9 billion